Biogen (BIIB) Profit Margin (2008 - 2026)
Biogen (BIIB) profit margin from Jun 30, 2008 to Mar 31, 2026. The current Biogen (BIIB) profit margin is 12.89%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Biogen (BIIB)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | 13.07% | -22.51% |
| 2024 | 16.87% | +42.89% |
| 2023 | 11.81% | -60.58% |
| 2022 | 29.95% | +111.36% |
| 2021 | 14.17% | -52.38% |
| 2020 | 29.76% | -27.34% |
| 2019 | 40.96% | -4.62% |
| 2019 | 42.94% | +3.94% |
| 2019 | 41.31% | +2.33% |
| 2019 | 40.37% | +22.57% |
| 2018 | 32.93% | -21.58% |
| 2018 | 42.00% | +62.68% |
| 2018 | 25.82% | -31.08% |
| 2018 | 37.46% | +81.08% |
| 2017 | 20.69% | -48.07% |
| 2017 | 39.84% | +42.13% |
| 2017 | 28.03% | +5.37% |
| 2017 | 26.60% | -17.76% |
| 2016 | 32.34% | -7.45% |
| 2016 | 34.94% | -3.66% |
| 2016 | 36.27% | +1.87% |
| 2016 | 35.61% | +8.05% |
| 2015 | 32.95% | -5.20% |
| 2015 | 34.76% | -2.85% |
| 2015 | 35.78% | +11.15% |
| 2015 | 32.19% | +6.44% |
| 2014 | 30.25% | -11.36% |
| 2014 | 34.12% | +15.64% |
| 2014 | 29.51% | +30.92% |
| 2014 | 22.54% | -16.11% |
| 2013 | 26.86% | +0.70% |
| 2013 | 26.68% | -6.30% |
| 2013 | 28.47% | -5.58% |
| 2013 | 30.15% | +20.53% |
| 2012 | 25.02% | -13.00% |
| 2012 | 28.75% | +5.64% |
| 2012 | 27.22% | +16.18% |
| 2012 | 23.43% | -4.18% |
| 2011 | 24.45% | -8.96% |
| 2011 | 26.86% | +12.71% |
| 2011 | 23.83% | -2.57% |
| 2011 | 24.46% | +14.75% |
| 2010 | 21.31% | -1.37% |
| 2010 | 21.61% | -10.68% |
| 2010 | 24.19% | +23.41% |
| 2010 | 19.61% | -11.54% |
| 2009 | 22.16% | -10.58% |
| 2009 | 24.78% | +89.75% |
| 2009 | 13.06% | -44.52% |
| 2009 | 23.54% | +23.16% |
| 2008 | 19.11% | -5.01% |
| 2007 | 20.12% | N/A |
Comparison Biogen (BIIB) profit margin with competitors
Biogen (BIIB) profit margin is 12.89%.
| Ticker | Name | Profit Margin | Upside |
|---|---|---|---|
| NVO | Novo Nordisk | 50.15% | +288.93% |
| LLY | Lilly(Eli) & Company | 37.36% | +189.74% |
| GILD | Gilead Sciences Inc | 29.04% | +125.21% |
| NVS | Novartis AG | 23.34% | +81.01% |
| BMY | Bristol-Myers Squibb Company | 23.30% | +80.70% |
| GSK | GSK Plc | 22.77% | +76.59% |
| JNJ | Johnson & Johnson | 21.76% | +68.75% |
| AMGN | AMGEN Inc | 21.11% | +63.71% |
| AZN | Astrazeneca plc | 20.15% | +56.27% |
| PFE | Pfizer Inc | 18.59% | +44.17% |
| SNY | Sanofi | 14.35% | +11.29% |
| OGN | Organon & Company | 10.00% | -22.45% |
| ABBV | Abbvie Inc | 4.63% | -64.09% |
| GRFS | Grifols SA | 4.29% | -66.73% |